CLENZIDERM PORE THERAPY

Product NDC
0187-6102
11-digit product format
001876102
Labeler code
0187
Product ID
0187-6102_a9b244f0-0d9a-4368-a558-e3e909e4e24c
Type
HUMAN OTC DRUG
Nonproprietary name
SALICYLIC ACID
Dosage form
SOLUTION
Route
TOPICAL
Labeler
Valeant Pharmaceuticals North America LLC
Application
part333D
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2015-03-02
Marketing end
0000-00-00
Substance
SALICYLIC ACID
Active strength
20 mg/mL
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0187-6102DDiscontinued by firm2026-08-11
excluded packagepackage0187-61020187-6102-04DDiscontinued by firm2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 30 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0187-6102-04DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0187-6102-04DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0187-6102-04DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0187-6102-04DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0187-6102-04DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0187-6102-04DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductDDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0187-6102-04DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductDDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0187-6102-04DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductDDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0187-6102-04DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductDDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0187-6102-04DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductDDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0187-6102-04DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductDDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0187-6102-04DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproductIInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage0187-6102-04IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproductIInactivated by FDA9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage0187-6102-04IInactivated by FDA9bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproductEExcluded after deficient or non-compliant submission was not corrected110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage0187-6102-04EExcluded after deficient or non-compliant submission was not corrected110d247fa046…a55b01930146…

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BENZOYL PEROXIDEACTIVE INGREDIENTW9WZN9A0GMCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
BENZOYL PEROXIDEACTIVE MOIETYW9WZN9A0GMCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
3-((L-MENTHYL)OXY)PROPANE-1,2-DIOLINACTIVE INGREDIENTKD6TZ2QICHCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
ALCOHOLINACTIVE INGREDIENT3K9958V90MCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W7CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
BENZYL BENZOATEINACTIVE INGREDIENTN863NB338GCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171KCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
CETYL HYDROXYETHYLCELLULOSE (350000 MW)INACTIVE INGREDIENTT7SWE4S2TTCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
COCAMIDOPROPYL BETAINEINACTIVE INGREDIENT5OCF3O11KXCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
DICAPRYLYL ETHERINACTIVE INGREDIENT77JZM5516ZCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
DIETHYLENE GLYCOL MONOETHYL ETHERINACTIVE INGREDIENTA1A1I8X02BCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
DIMETHYL ISOSORBIDEINACTIVE INGREDIENTSA6A6V432SCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
EXT. D&C VIOLET NO. 2INACTIVE INGREDIENTG5UX3K0728CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
GLYCERININACTIVE INGREDIENTPDC6A3C0OXCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)INACTIVE INGREDIENT86FQE96TZ4CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
MENTHOLINACTIVE INGREDIENTL7T10EIP3ACLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
MENTHYL LACTATE, (-)-INACTIVE INGREDIENT2BF9E65L7ICLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4MCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
SODIUM LAURETH-3 SULFATEINACTIVE INGREDIENTBPV390UAP0CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
SQUALANEINACTIVE INGREDIENTGW89575KF9CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
WATERINACTIVE INGREDIENT059QF0KO0RCLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]2
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
3-((L-MENTHYL)OXY)PROPANE-1,2-DIOLINACTIVE INGREDIENTKD6TZ2QICHCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
ALCOHOLINACTIVE INGREDIENT3K9958V90MCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W7CLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
DIETHYLENE GLYCOL MONOETHYL ETHERINACTIVE INGREDIENTA1A1I8X02BCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
EXT. D&C VIOLET NO. 2INACTIVE INGREDIENTG5UX3K0728CLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
MENTHOLINACTIVE INGREDIENTL7T10EIP3ACLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
MENTHYL LACTATE, (-)-INACTIVE INGREDIENT2BF9E65L7ICLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1
WATERINACTIVE INGREDIENT059QF0KO0RCLENZIDERM PORE THERAPY ACNE TREATMENT (SALICYLIC ACID) SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]1